Corrigendum to “Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study” [Genomics. 2021 Mar;113(2):507–514]. (Genomics (2021) 113(2) (507–514), (S0888754320320772), (10.1016/j.ygeno.2020.12.030))

Mu Hong Chen, Chung Feng Kao, Shih Jen Tsai*, Cheng Ta Li, Wei Chen Lin, Chen Jee Hong, Ya Mei Bai, Pei Chi Tu, Tung Ping Su

*此作品的通信作者

研究成果: Comment/debate

摘要

The authors regret “We found a typo in the method section in our paper. Wrong one: “All participants were genotyped using Illumina Human Omni Express Exome Bead Chips” in the 2.2. Genotyping and quality controls section. Correct one: “All participants were genotyped using the Taiwan Biobank chips (TWB 2.0; 686,463 SNPs) (Affymetrix, Santa Clara, CA, USA)” in the 2.2. Genotyping and quality controls section”. The authors would like to apologise for any inconvenience caused.

原文English
期刊Genomics
DOIs
出版狀態Accepted/In press - 2021

指紋

深入研究「Corrigendum to “Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study” [Genomics. 2021 Mar;113(2):507–514]. (Genomics (2021) 113(2) (507–514), (S0888754320320772), (10.1016/j.ygeno.2020.12.030))」主題。共同形成了獨特的指紋。

引用此